Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for DePuy Inc.�
103.73
+0.78 (0.76%)
Aug 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 103.01 - 103.76
52 week 85.50 - 106.74
Open 103.10
Vol / Avg. 5.29M/5.87M
Mkt cap 292.55B
P/E 19.17
Div/yield 0.70/2.70
EPS 5.41
Shares 2.82B
Beta 0.56
Inst. own 67%
Oct 13, 2014
Q3 2014 Johnson & Johnson Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 15, 2014
Q2 2014 Johnson & Johnson Earnings Release
Jul 15, 2014
Q2 2014 Johnson & Johnson Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 22.19% 19.40%
Operating margin 28.86% 21.69%
EBITD margin - 33.30%
Return on average assets 12.92% 10.89%
Return on average equity 22.44% 19.92%
Employees 128,100 -
CDP Score - 98 A-

Address

ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 8933
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. In March 2013, Johnson & Johnson's Cordis Corporation announced the acquisition of Flexible Stenting Solutions, Inc. In June 2013, Johnson & Johnson announced the opening of the Johnson & Johnson Innovation center in Boston. In July 2014, Johnson & Johnson completed the divestiture of Ortho-Clinical Diagnostics business to Carlyle Group.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 56
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 55
Bio & Compensation  - Reuters
Paulus Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 52
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 55
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 51
Bio & Compensation  - Reuters
Ernesto Quinteros Chief Design Officer
Age: 51
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
D. Scott Davis Director
Age: 62
Bio & Compensation  - Reuters
Mary Sue Coleman Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters